DOUGLAS, ISLE OF MAN, GB / ACCESS Newswire / October 21, 2025 / Agronomics (LSE:ANIC), the leading listed company in the field of clean food, is pleased to announce that its portfolio company Geltor, Inc. ("Geltor") has received a ‘No Questions’ Letter from the US Food and Drug Administration ("FDA"), confirming the Generally Recognized As […]
Empowering People to See – and Change – Their Future Selves, withNoom as the First Partner Haut.AI, the global leader in AI-powered skin analysis and longevity innovation, today announced the launch of SkinGPT's Aging Model, a new generative AI technology capable of realistically simulating up to 40 years of skin aging under different lifestyle and
— Codis appoints Steven Facer as Senior VP Sales & Marketing, bringing over 30 years of international pharmaceutical leadership experience. — Proven track record atAdare, Thermo Fisher, Capsugel and Catalent driving commercial growth, strategic partnerships, and global market expansion. — Will leadCodis's Haverhill sales and marketing strategy, strengthen customer partnerships and accelerate the company's growth
The 2025 MUSE Creative and Design Awards, organized by the International Awards Associate (IAA), has officially announced its Season 2 results, marking the second chapter of this year's global competition while celebrating the program's 10th anniversary milestone. From more than 13,000 submissions, this season's winners embody innovation, craft, and influence across the creative and design
(NASDAQ:SWTX), STAMFORD, Conn., Oct. 21, 2025 (GLOBE NEWSWIRE) — SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany, announced today that long-term efficacy and safety data from the Phase 3 DeFi trial of OGSIVEO(R) (nirogacestat), an oral gamma secretase inhibitor for the treatment of adults with progressing desmoid tumors who require systemic treatment,
(NASDAQ:SPRO),(NYSE:GSK),(LSE:GSK.L), Data presented at IDWeek 2025 after study stopped early for efficacy Primary endpoint met, demonstrating non-inferiority of oral tebipenem HBr compared to intravenous treatment1 Data will be shared with regulatory authorities to support regulatory filings CAMBRIDGE, Mass., Oct. 21, 2025 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO) and GSK plc (LSE/NYSE: GSK) today
(NYSE MKT:CMCL),(LSE – AIM:CMCL),(LSE:CMCL.L),(LSE:CMCL.LN), ST HELIER, Jersey, Oct. 21, 2025 (GLOBE NEWSWIRE) — Caledonia Mining Corporation Plc (NYSE AMERICAN, AIM and VFEX: CMCL) (“Caledonia” or “the Company”) announces gold production from the Blanket Mine in Zimbabwe (“Blanket”) for the quarter ended September 30, 2025 (“Q3 2025” or the “Quarter”). All production numbers are expressed on
(Paris:STMPA),(NYSE:STM), Singapore's largest industrial district cooling system begins operationsto support STMicroelectronics' decarbonization strategy Designed, built, owned, and operated by a joint venture between SP Group and Daikin Airconditioning (Singapore), the innovative district cooling system will significantly improve the environmental performance of ST's high-volume semiconductor manufacturing site in Singapore New system expected to reduce carbon emissions
(LSE – AIM:AMRQ),(Iceland:AMRQ),(TSX-V:AMRQ),(OTC US:AMRQF),(OTCQX:AMRQF), Reykjavík, Oct. 21, 2025 (GLOBE NEWSWIRE) — Amaroq Ltd.(“Amaroq” or the “Company”) Notice to holders of Icelandic Depository Receipts Simplification and streamlining of Amaroq's securities under a single ISIN TORONTO, ONTARIO – 21 October 2025 – Amaroq Ltd. (AIM, TSX-V, NASDAQ Iceland: AMRQ, OTCQX: AMRQF), announces that its Icelandic Depositary Receipts
(Euronext Amsterdam:INGA),(Brussels:INGA), Progress on share buyback programme ING announced today that, as part of our EUR2.0 billion share buyback programme announced on 2 May 2025, in total 4,381,000 shares were repurchased during the week of 13 October 2025 up to and including 17 October 2025. The shares were repurchased at an average price of EUR20.91